Panbela Therapeutics Inc
OTC:PBLA
Panbela Therapeutics Inc
OTC:PBLA
Price:
0.0111
USD
Market Closed
Market Cap:
$53.8k
Balance Sheet
Balance Sheet Decomposition
Panbela Therapeutics Inc
Panbela Therapeutics Inc
Balance Sheet Decomposition is not available for
Panbela Therapeutics Inc
Panbela Therapeutics Inc
Balance Sheet
Panbela Therapeutics Inc
Panbela Therapeutics Inc
Currency: USD
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
1
|
2
|
9
|
12
|
1
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
9
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
1
|
0
|
0
|
12
|
1
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
2
|
3
|
10
|
12
|
2
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
9
|
|
| Total Assets |
0
N/A
|
0
-9%
|
1
+141%
|
1
-13%
|
2
+366%
|
2
-30%
|
1
-49%
|
1
-13%
|
2
+147%
|
3
+66%
|
10
+212%
|
13
+31%
|
5
-61%
|
12
+137%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
10
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
2
|
3
|
1
|
|
| Short-Term Debt |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
0
|
1
|
6
|
4
|
2
|
2
|
1
|
3
|
8
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-8%
|
1
-1%
|
1
+3%
|
4
+466%
|
4
+16%
|
6
+25%
|
4
-19%
|
2
-63%
|
2
+8%
|
1
-22%
|
3
+95%
|
13
+390%
|
17
+27%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
14
|
14
|
14
|
14
|
9
|
14
|
19
|
29
|
35
|
41
|
46
|
56
|
91
|
125
|
|
| Additional Paid In Capital |
13
|
13
|
13
|
13
|
7
|
11
|
14
|
26
|
35
|
42
|
55
|
66
|
82
|
120
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
0
N/A
|
0
+7%
|
0
+90%
|
0
-237%
|
1
-854%
|
3
-104%
|
5
-73%
|
4
+21%
|
0
N/A
|
1
+417%
|
8
+510%
|
10
+21%
|
8
N/A
|
5
+41%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-9%
|
1
+141%
|
1
-13%
|
2
+366%
|
2
-30%
|
1
-49%
|
1
-13%
|
2
+147%
|
3
+66%
|
10
+212%
|
13
+31%
|
5
-61%
|
12
+137%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
